M&A Deal Of The Year


M&A DEAL OF THE YEAR

This award recognises the teams and organisations who have executed a truly transformational and high value M&A deal for both the company and the wider industry. 

Qualifying criteria

  • The lead company must be a European Life Science company
  • Open to private, public companies, pharma, commercial leaders or big tech
  • Deal must be an M&A deal NOT a license, partnership or alliance
  • Deal to have completed in the period between 1 October 2020 and 1 October 2021

Judges will be paying particular attention to:

  • Uniqueness or novelty of deal strategy / terms and structure
  • Level of value creation / size of deal
  • Strength of acquirers existing pipeline / synergy with existing portfolio
  • Potential game / industry changing implications within next 12-months
  • Post-deal performance
Before entering the nomination site please ensure you have:

1. Selected the most appropriate category(s) you'll be entering and check for validity of entry
2. Identified your lead applicant / internal champion who will respond to any correspondence from the ELA team
3. Pre-prepared your submission in accordance with the category criteria, spending time crafting your detailed submission.
4. A company logo and your website URL that you can upload alongside your submission

ENTRIES OPEN. NOMINATE HERE